文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Leiomyoma with Bizarre Nuclei and Hereditary Leiomyomatosis and Renal Cell Carcinoma.

作者信息

Uzianbaeva Liaisan, Moustafa Salma, Paczos Tamera, Suskin Emily, Said-Delgado Sara, Rabin-Havt Sara, Wang Pengfei

机构信息

Department of Obstetrics and Gynecology, BronxCare Health System, Bronx, NY, USA. (Drs. Uzianbaeva, Moustafa, Said-Delgado, and Wang).

Department of Pathology, BronxCare Health System, Bronx, NY, USA. (Dr. Paczos).

出版信息

CRSLS. 2025 Apr 29;12(2). doi: 10.4293/CRSLS.2025.00015. eCollection 2025 Apr-Jun.


DOI:10.4293/CRSLS.2025.00015
PMID:40321900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12046535/
Abstract

INTRODUCTION: Leiomyoma with bizarre nuclei (LBN) is a leiomyoma variant that can be associated with fumarate hydratase (FH) deficiency. Germline pathogenic variants in the gene are linked to hereditary leiomyomatosis and renal cell carcinoma (HLRCC), which presents with cutaneous leiomyomata, aggressive renal cell carcinomas (RCCs), and symptomatic uterine leiomyomas. CASE DESCRIPTION: A 22-year-old nulligravida female presented with multiple uterine fibroids, heavy menstrual bleeding and pelvic pain, lasting over two years. The patient subsequently underwent laparoscopic myomectomy. Histological analysis of the leiomyomas indicated the presence of bizarre nuclei. Immunohistochemical studies confirmed FH deficiency, characterized by loss of FH expression and overexpression of S-(2-succino)-cysteine (2SC). Genetic testing revealed a likely pathogenic variant (c. 1176_1181delTGCTGT) in the gene. DISCUSSION: Due to potentially devastating consequence and the occult nature of RCCs, the discovery of LBN should be followed with further investigation for HLRCC.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0df/12046535/7429a7194d57/LS-JSLS250019F002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0df/12046535/3ed286ecf9f0/LS-JSLS250019F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0df/12046535/7429a7194d57/LS-JSLS250019F002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0df/12046535/3ed286ecf9f0/LS-JSLS250019F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0df/12046535/7429a7194d57/LS-JSLS250019F002.jpg

相似文献

[1]
Leiomyoma with Bizarre Nuclei and Hereditary Leiomyomatosis and Renal Cell Carcinoma.

CRSLS. 2025-4-29

[2]
Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

Am J Surg Pathol. 2013-1

[3]
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

Am J Surg Pathol. 2016-7

[4]
Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).

Am J Surg Pathol. 2019-9

[5]
Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach.

Genes Chromosomes Cancer. 2020-11

[6]
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.

Cancer. 2017-7-1

[7]
Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients.

Histopathology. 2020-1-13

[8]
Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC).

Virchows Arch. 2015-8

[9]
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.

Clin Genet. 2017-5-2

[10]
The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.

Pathol Res Pract. 2024-1

本文引用的文献

[1]
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Pheochromocytoma and Paraganglioma.

Am J Surg Pathol. 2023-1-1

[2]
2020 WHO Classification of Female Genital Tumors.

Geburtshilfe Frauenheilkd. 2021-10

[3]
Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation.

Cell Death Dis. 2018-9-6

[4]
A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC).

Fam Cancer. 2018-10

[5]
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.

Virchows Arch. 2018-1-13

[6]
Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.

Int J Gynecol Pathol. 2018-9

[7]
Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.

J Am Acad Dermatol. 2017-3-14

[8]
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.

Nature. 2016-8-31

[9]
Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.

Am J Surg Pathol. 2016-12

[10]
Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.

Am J Dermatopathol. 2016-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索